ROYAL BANK OF CANADA - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 32 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$1,0000.0%1,000
-23.1%
0.00%
Q1 2019$1,0000.0%1,300
+30.0%
0.00%
Q4 2018$1,0001,000
+2531.6%
0.00%
Q1 2017$038
-87.3%
0.00%
Q2 2016$03000.0%0.00%
Q1 2016$03000.0%0.00%
Q4 2015$0
-100.0%
3000.0%0.00%
Q3 2015$1,0000.0%3000.0%0.00%
Q2 2015$1,0000.0%3000.0%0.00%
Q1 2015$1,0000.0%3000.0%0.00%
Q4 2014$1,0000.0%3000.0%0.00%
Q3 2014$1,000
-90.0%
300
-90.0%
0.00%
Q3 2013$10,000
+11.1%
3,0000.0%0.00%
Q2 2013$9,0003,0000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 85,378$301,0000.33%
Tower Research Capital LLC (TRC) 54,690$193,0000.03%
Psagot Value Holdings Ltd. 54,348$191,0000.01%
OPPENHEIMER & CO INC 36,450$128,0000.00%
MEEDER ASSET MANAGEMENT INC 2,900$10,0000.00%
TWO SIGMA INVESTMENTS, LP 34,571$121,0000.00%
Commonwealth Equity Services, Inc 11,100$39,0000.00%
GROUP ONE TRADING, L.P. 18,844$66,0000.00%
CITIGROUP INC 737$3,0000.00%
VAN ECK ASSOCIATES CORP 21,179$75,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders